ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Clinical trials for ALK-POSITIVE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ALK-POSITIVE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ALK-POSITIVE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Tough-to-Treat lung cancer in groundbreaking trial
Disease control Recruiting nowThis study is testing a new oral medication called TRI-611 for adults with advanced ALK-positive non-small cell lung cancer. The first part aims to find a safe and effective dose, while the second part will see how well the drug works in different groups of patients based on thei…
Matched conditions: ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New program aims to ease the emotional burden of living with advanced lung cancer
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with advanced lung cancer who are receiving targeted therapy. The program involves four visits with a specially trained palliative care clinician to help patients cope with uncertainty about the future an…
Matched conditions: ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC